Clinical trial
Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or…
NCT00472329 · Colorado Blood Cancer Institute, Other · Unknown status
Key facts
| NCT number | NCT00472329 |
|---|---|
| Title | Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant |
| Official title | Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant |
| Lead sponsor | Colorado Blood Cancer Institute, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Failure |
| Intervention type | Drug, Procedure |
| Interventions | Allogeneic hematopoietic stem cell graft using an allogeneic SCT HLA-Identical or non-identical family donor or unrelated donors, fludarabine, TBI |
| Enrollment | 20 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2020 |
| Completion | Dec 1, 2020 |
| First posted | May 11, 2007 |
| Last update posted | Jun 30, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: